How to Read Your Gene2Rx Pharmacogenetics Report (and How to Use It)

Gene2Rx reports are designed to translate genetic results into practical, medication-relevant insights. If you have ever wondered why a medication works well for someone else but causes side effects for you, pharmacogenetics (PGx) can be one useful piece of the explanation.

This guide walks through what’s in the Gene2Rx report, what the icons mean, and how to interpret the medication tables in a clear, clinician-friendly way.

You can follow along using the example report here: https://gene2rx.com/example/html/full_report/

First, a safety note

Your Gene2Rx report is educational and intended to support conversations with your healthcare provider. Do not change your dose or stop a medication without speaking with a qualified clinician.

What the report is (and what it is not)

What it is

• A summary of pharmacogenetic variants inferred from the genetic data you uploaded.
• A translation of those variants into predicted phenotypes (for example, normal, intermediate, poor metabolizer, decreased function).
• A medication list organized into:
• Drugs with Potential Atypical Response
• Drugs with Typical Response
• Links to relevant guidance sources (commonly CPIC and FDA).

What it is not

• Not a diagnosis.
• Not a guarantee of how you will respond to any medication.
• Not a substitute for clinical testing or medical advice.

A key theme: PGx shifts probabilities. It does not determine outcomes by itself.

Step 1: Start with “Report Information”

At the top, the report lists: - Date of report - Data source (example: 23andMe) - Report version

These details matter because PGx recommendations evolve over time as research and professional guidelines are updated.

Step 2: Understand the overall layout

The report is built around four main sections: 1. Pharmacogenetics Summary 2. Atypical Response Drugs 3. Typical Response Drugs 4. FAQ

A practical reading order is: - Summary first (your genes) - Atypical drugs next (most actionable) - Typical drugs for context - FAQ for next steps and limitations

Step 3: Read the “Pharmacogenetics Summary” table

This is your “gene results” dashboard. Each row includes:

Gene

Examples include CYP2D6, CYP2C19, SLCO1B1, CYP2C9, ABCG2.

Genotype

This is the pair of alleles or variants detected for that gene. Many genes are expressed in “star allele” format (for example, 1/2), while others are shown as variant calls (rsIDs).

Phenotype

This is the predicted functional consequence of the genotype. This is the clinically useful layer because most prescribing guidance is written using phenotypes.

How to think about phenotypes: - Metabolizer genes (CYPs): - Poor metabolizer often means slower breakdown of certain drugs, which can increase drug levels and side effects, depending on the drug. - Rapid or ultrarapid metabolizer can mean faster breakdown, sometimes lowering drug levels and reducing efficacy, depending on the drug. - Transporter genes (like SLCO1B1): - Decreased function can increase exposure to some drugs, which can raise side effect risk for certain medications. - Not every non-normal result changes prescribing. The report legend calls this out directly: an altered allele does not automatically mean altered drug response for every drug.

Step 4: Use the Legend and the “Therapeutic Guidance” icons

Two different “visual languages” appear in the report:

A) Gene function symbols (in the gene summary)

These icons indicate predicted gene function (normal, decreased, increased, severely decreased/no function, or unknown).

B) Therapeutic guidance symbols (in the drug tables)

In the Atypical Response Drugs section, each medication row includes a guidance icon, typically interpreted as: - Normal therapeutic guidance: no PGx-based change suggested by the referenced guidance - Alternate dosing recommended - Alternate drug recommended

Important nuance: sometimes a phenotype may be labeled “unknown” in terms of effect on a specific drug, and the report may still show normal guidance because no actionable recommendation exists.

Step 5: Read the “Atypical Response Drugs” tables like a pro

This section is where most people should spend their time.

Each row typically includes: - Generic name (and sometimes a link to a Gene2Rx drug page) - Brand names - Gene - Your phenotype - Implication (plain-language explanation) - Source (CPIC and/or FDA link)

How to interpret a row (use this 3-question method)

1) What is the drug and what is it used for in my case?
Some drugs appear in a category based on a common use, but you may take them for a different indication.

2) Is the issue likely efficacy, side effects, or either?
- Higher exposure often maps to side-effect risk. - Lower exposure can map to reduced efficacy. - Some drugs are prodrugs, where reduced activation can reduce efficacy.

3) What does the guidance actually recommend?
Use the Source links in the row to open the CPIC guideline or FDA association table and see the clinician-oriented recommendation.

Multi-gene medications

Some drugs have guidance based on more than one gene. The report notes that it evaluates each gene separately and groups results together. When you see multiple genes involved, it is worth reviewing the full entry carefully since the recommendation can depend on the combination.

Step 6: Don’t ignore the “Typical Response Drugs” section

This section is useful for context: - “Typical response” does not mean you will have no side effects. - It means that, based on the genes assessed and current guidance, there is no PGx-based reason to expect an atypical response for that drug.

Clinically, this can help narrow options when you and your clinician are choosing between several medications.

Step 7: The FAQ section answers the most common “what now?” questions

The FAQ reinforces key points, including: - If a drug is not listed, it may not have published PGx prescribing guidance. - PGx guidance can change as evidence evolves, even though your DNA does not. - Uploaded genotyping data can be incomplete, and some types of genetic variation may not be captured in direct-to-consumer files.

How to bring this report to your next appointment

If you want to make this report maximally useful in a short visit, bring:

1. A list of your current medications, doses, and what you are taking them for.
2. The medications flagged in Atypical Response Drugs that overlap with what you take (or are considering).
3. For each flagged medication:
4. the gene involved
5. your phenotype
6. the one-sentence implication
7. the linked source (CPIC or FDA)

Then ask: - “Does this help explain side effects or lack of benefit I experienced?” - “If we keep this medication, should we adjust dose or titration?” - “If we switch, what alternatives fit the same clinical goal with less PGx risk?” - “Should we confirm anything with clinical-grade testing given my situation?”

Bottom line

The most important idea is simple: your Gene2Rx report is a structured way to connect genetics to medications using established guidance. The best use case is not self-adjustment. It is better questions, better conversations, and less trial-and-error with your healthcare team.